US Stock MarketDetailed Quotes

TVGN Tevogen Bio Holdings

Watchlist
  • 0.996
  • +0.031+3.26%
Close Dec 20 16:00 ET
  • 0.983
  • -0.013-1.31%
Post 19:54 ET
174.35MMarket Cap-12.45P/E (TTM)

Tevogen Bio Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
161.74%6.09M
293.64%8.6M
1,169.93%29.52M
138.59%2.27M
-4.56M
2.33M
2.18M
2.32M
-79.36%953.08K
4.62M
Selling and administrative expenses
133.80%2.82M
288.06%4.47M
790.91%8.71M
138.59%2.27M
---1.06M
--1.21M
--1.15M
--977.11K
-42.68%953.08K
--1.66M
-General and administrative expense
133.80%2.82M
288.06%4.47M
790.91%8.71M
138.59%2.27M
---1.06M
--1.21M
--1.15M
--977.11K
-42.68%953.08K
--1.66M
Research and development costs
191.96%3.26M
299.89%4.12M
1,444.83%20.81M
----
----
--1.12M
--1.03M
--1.35M
----
--2.96M
Operating profit
-161.74%-6.09M
-293.64%-8.6M
-1,169.93%-29.52M
-138.59%-2.27M
4.56M
-2.33M
-2.18M
-2.32M
79.36%-953.08K
-4.62M
Net non-operating interest income expense
95.85%-12.46K
100.00%6
46.09%-155.79K
-256.03K
632.8K
-299.94K
-299.89K
-289K
0
-598.5K
Non-operating interest expense
-95.85%12.46K
----
-46.09%155.79K
--256.03K
---632.8K
--299.94K
----
--289K
--0
--598.5K
Total other finance cost
----
-100.00%-6
----
----
----
----
--299.89K
----
----
----
Other net income (expense)
116.70%213.76K
94.60%-1.06M
245.46%40.94M
-54.07%2.46M
51.59M
-1.28M
-19.7M
-28.14M
151.65%5.36M
-10.38M
Gain on sale of security
--213.76K
---174.43K
---31.97K
-49.40%2.71M
----
----
----
----
--5.36M
----
Special income (charges)
--0
--0
---7.5M
---250K
---250K
--0
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
--0
--0
--7.5M
----
----
--0
--0
--0
----
----
-Write off
----
----
----
--250K
----
----
----
----
--0
----
Other non- operating income (expenses)
----
95.48%-890K
272.22%48.47M
----
----
---1.28M
---19.7M
---28.14M
----
---10.38M
Income before tax
-50.69%-5.88M
56.44%-9.66M
136.63%11.26M
-101.53%-67.33K
56.78M
-3.9M
-22.18M
-30.76M
128.26%4.41M
-15.6M
Income tax
Net income
-50.69%-5.88M
56.44%-9.66M
136.63%11.26M
-101.53%-67.33K
56.78M
-3.9M
-22.18M
-30.76M
128.26%4.41M
-15.6M
Net income continuous Operations
-50.69%-5.88M
56.44%-9.66M
136.63%11.26M
-101.53%-67.33K
--56.78M
---3.9M
---22.18M
---30.76M
128.26%4.41M
---15.6M
Minority interest income
Net income attributable to the parent company
-50.69%-5.88M
56.44%-9.66M
136.63%11.26M
-101.53%-67.33K
56.78M
-3.9M
-22.18M
-30.76M
128.26%4.41M
-15.6M
Preferred stock dividends
Other preferred stock dividends
25.21K
-3.59M
757.98K
0
0
0
Net income attributable to common stockholders
-51.33%-5.91M
72.61%-6.08M
134.16%10.51M
-101.53%-67.33K
56.78M
-3.9M
-22.18M
-30.76M
128.26%4.41M
-15.6M
Basic earnings per share
-21.47%-0.03
71.49%-0.04
130.77%0.08
-101.16%-0.0004
0.3591
-0.0247
-0.1403
-0.26
128.26%0.0367
-0.13
Diluted earnings per share
-21.47%-0.03
71.49%-0.04
0.00%-0.26
-101.16%-0.0004
0.3591
-0.0247
-0.1403
-0.26
128.26%0.0367
-0.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 161.74%6.09M293.64%8.6M1,169.93%29.52M138.59%2.27M-4.56M2.33M2.18M2.32M-79.36%953.08K4.62M
Selling and administrative expenses 133.80%2.82M288.06%4.47M790.91%8.71M138.59%2.27M---1.06M--1.21M--1.15M--977.11K-42.68%953.08K--1.66M
-General and administrative expense 133.80%2.82M288.06%4.47M790.91%8.71M138.59%2.27M---1.06M--1.21M--1.15M--977.11K-42.68%953.08K--1.66M
Research and development costs 191.96%3.26M299.89%4.12M1,444.83%20.81M----------1.12M--1.03M--1.35M------2.96M
Operating profit -161.74%-6.09M-293.64%-8.6M-1,169.93%-29.52M-138.59%-2.27M4.56M-2.33M-2.18M-2.32M79.36%-953.08K-4.62M
Net non-operating interest income expense 95.85%-12.46K100.00%646.09%-155.79K-256.03K632.8K-299.94K-299.89K-289K0-598.5K
Non-operating interest expense -95.85%12.46K-----46.09%155.79K--256.03K---632.8K--299.94K------289K--0--598.5K
Total other finance cost -----100.00%-6------------------299.89K------------
Other net income (expense) 116.70%213.76K94.60%-1.06M245.46%40.94M-54.07%2.46M51.59M-1.28M-19.7M-28.14M151.65%5.36M-10.38M
Gain on sale of security --213.76K---174.43K---31.97K-49.40%2.71M------------------5.36M----
Special income (charges) --0--0---7.5M---250K---250K--0--0--0--0----
-Less：Restructuring and merger&acquisition --0--0--7.5M----------0--0--0--------
-Write off --------------250K------------------0----
Other non- operating income (expenses) ----95.48%-890K272.22%48.47M-----------1.28M---19.7M---28.14M-------10.38M
Income before tax -50.69%-5.88M56.44%-9.66M136.63%11.26M-101.53%-67.33K56.78M-3.9M-22.18M-30.76M128.26%4.41M-15.6M
Income tax
Net income -50.69%-5.88M56.44%-9.66M136.63%11.26M-101.53%-67.33K56.78M-3.9M-22.18M-30.76M128.26%4.41M-15.6M
Net income continuous Operations -50.69%-5.88M56.44%-9.66M136.63%11.26M-101.53%-67.33K--56.78M---3.9M---22.18M---30.76M128.26%4.41M---15.6M
Minority interest income
Net income attributable to the parent company -50.69%-5.88M56.44%-9.66M136.63%11.26M-101.53%-67.33K56.78M-3.9M-22.18M-30.76M128.26%4.41M-15.6M
Preferred stock dividends
Other preferred stock dividends 25.21K-3.59M757.98K000
Net income attributable to common stockholders -51.33%-5.91M72.61%-6.08M134.16%10.51M-101.53%-67.33K56.78M-3.9M-22.18M-30.76M128.26%4.41M-15.6M
Basic earnings per share -21.47%-0.0371.49%-0.04130.77%0.08-101.16%-0.00040.3591-0.0247-0.1403-0.26128.26%0.0367-0.13
Diluted earnings per share -21.47%-0.0371.49%-0.040.00%-0.26-101.16%-0.00040.3591-0.0247-0.1403-0.26128.26%0.0367-0.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List